TickerFacts.

Burning Rock Biotech Ltd (BNR): Net Income

Annual figures by period end, from SEC filings.

-55.35M CNY
Year ended 2025-12-31
2018-12-31: -177.50M CNY2019-12-31: -169.16M CNY2020-12-31: -407.24M CNY2021-12-31: -796.70M CNY2022-12-31: -971.23M CNY2023-12-31: -653.69M CNY2024-12-31: -346.63M CNY2025-12-31: -55.35M CNY-55.35M CNY
2018-12-31 Net Income (CNY) 2025-12-31
Period endedNet IncomeChange YoYSource filing
2025-12-31-55.35M CNYn/m2026-04-28, From 2025-01-01
2024-12-31-346.63M CNYn/m2026-04-28, From 2024-01-01
2023-12-31-653.69M CNYn/m2026-04-28, From 2023-01-01
2022-12-31-971.23M CNYn/m2025-04-29, From 2022-01-01
2021-12-31-796.70M CNYn/m2024-04-29, From 2021-01-01
2020-12-31-407.24M CNYn/m2023-04-20, From 2020-01-01
2019-12-31-169.16M CNYn/m2022-04-29, From 2019-01-01
2018-12-31-177.50M CNYn/a2021-03-23, From 2018-01-01

Net Income at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedNet IncomeChange YoY
Burning Rock Biotech Ltd (BNR)2025-12-31-55.35M CNYn/m
Concord Medical Services Holdings Ltd (CCM)2025-12-31-92.81M CNYn/m

Compare BNR, CCM side by side · Screen every company in Services-Medical Laboratories ↗